Cargando…
Targeting Cognitive Impairment in Multiple Sclerosis—The Road toward an Imaging-based Biomarker
Multiple Sclerosis (MS) is a neuro-degenerative and -inflammatory disease leading to physical and cognitive impairment, pathological fatigue and depression, and affecting patients' quality of life and employment status. The combination of inflammation, demyelination, and neurodegeneration leads...
Autores principales: | Van Schependom, Jeroen, Nagels, Guy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5491975/ https://www.ncbi.nlm.nih.gov/pubmed/28713238 http://dx.doi.org/10.3389/fnins.2017.00380 |
Ejemplares similares
-
Towards Multimodal Machine Learning Prediction of Individual Cognitive Evolution in Multiple Sclerosis
por: Denissen, Stijn, et al.
Publicado: (2021) -
Brain dysconnectivity relates to disability and cognitive impairment in multiple sclerosis
por: Sjøgård, Martin, et al.
Publicado: (2020) -
The spectral slope as a marker of excitation/inhibition ratio and cognitive functioning in multiple sclerosis
por: Akbarian, Fahimeh, et al.
Publicado: (2023) -
Occurrence and Severity of Coronavirus Disease 2019 Are Associated With Clinical Disability Worsening in Patients With Multiple Sclerosis
por: Peeters, Gertjan, et al.
Publicado: (2023) -
The Impact of Cognitive Dysfunction on Locomotor Rehabilitation Potential in Multiple Sclerosis
por: Denissen, Stijn, et al.
Publicado: (2019)